Rising Incidence of Infectious Diseases and Outbreak of Epidemics
The diseases such as HIV/AIDS, Hepatitis, severe acute respiratory syndrome (SARS) and the 2009 pandemic H1N1 influenza and 2014 Ebola virus infections, are some of the examples for rising incidence of the infectious diseases in the modern world. There are several other factors that precipitate the disease emergence, which includes ecological, environmental, or demographical factors. These factors, along with the ongoing evolution of viral and microbial variants and selection for drug resistance, suggest that infections will continue to emerge and increase in the coming years, which in turn, emphasizes the urgent need for effective surveillance, control, and microbiology testing. Hence these are some of the factors propelling the growth of the market.
The other factors includes technological advancements in microbiology testing, rising incidence of infectious diseases and outbreak of epidemics, growing healthcare
expenditure and the rising private-public funding for research on infectious diseases.
High Cost of Microbiology Instruments
One of the biggest complaints that customers consistently have is regarding the laboratory industry which takes too long for labs to process the analytical results. Therefore, instrumentation manufacturers in recent years have focused on developing new advanced methods that save time, but cost more. Microbiology is an expensive laboratory service because it is labor intensive. It requires skilled laboratory personnel. Staff salaries generally account for 60-70% of the microbiology laboratory’s operating budget, which most of the times, is incurred on customers in the form of test costs. Based on the above-mentioned factors, high costs are hindering the microbiology testing market growth.
The other factor also include laboratory reimbursement issues.
North America hold the major market
Based on geography, the microbiology testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and MEA. North-America, followed by Europe, held the largest market share, in terms of revenue. North America accounts for the highest share among the all regions in the global microbiology testing market, owing to the presence of a large number of market-focused key players, who focus on providing wide product portfolios, and the growing demand for high-quality and standardized products & services that are essential to keep up with the pressure of international standards.
Key Developments in the Market
- January 2017, Abbott acquired St. Jude Medical, making the company a leader in the medical device sector.
- June 2017, Bio-Rad launched RT-PCR Assay Kit, for the detection of Zika, Dengue and Chikungunya viruses.
- March 2017: Xpert MTB/RIF Ultra was launched by Cepheid, for better diagnosis of TB in children and individuals with HIV.
- February 2017: Xpert Xpress Flu and Xpert Xpress Flu/RSV by Cepheid were indicated for healthcare-associated infections, sexual health, critical infectious disease, and oncology.
Reasons to Purchase this Report
- Current and future microbiology testing market outlook in the developed and emerging markets
- Analyzing various perspectives of the market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet (in Excel).
This report can be customized to meet your requirements. Please contact us for more information.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power Of Suppliers
5.2.2 Bargaining Power Of Consumers
5.2.3 Threats Of New Entrants
5.2.4 Threat Of Substitute Product & Services
5.2.5 Competitive Rivalry Within The Industry
6. Drivers, Restraints, Opportunities, And Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Technological Advancements In Microbiology Testing
6.1.2 Rising Incidence Of Infectious Diseases And Outbreak Of Epidemics
6.1.3 Growing Healthcare Expenditure
6.1.4 Rising Private-Public Funding For Research On Infectious Diseases
6.2 Market Restraints
6.2.1 Laboratory Reimbursement Issues
6.2.2 High Cost Of Microbiology Instruments
6.4 Key Challenges
7. Market Segmentation
7.1 Segmentation-By Application
7.1.1 Pharmaceutical Application
7.1.2 Diagnostic Application
7.1.3 Food & Beverage Testing Application
7.1.4 Environmental Application
7.1.5 Cosmetic Application
7.2 By Product
7.3 Segmentation-By Geography
7.3.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest Of Europe
220.127.116.11 Australia & New Zealand
18.104.22.168 South Korea
22.214.171.124 Rest Of Asia-Pacific
7.3.4 Middle East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest Of The Middle East & Africa
7.3.5 South America
184.108.40.206 Rest Of South America
8. Competitive Landscape
8.1 Mergers And Acquisition Analysis
8.2 Agreements, Collaborations, And Partnerships
8.3 New Products Launches
9. Key Players
9.1 Bio-Rad Laboratories Inc.
9.2 Abbott Laboratories
9.3 Becton Dickinson
9.4 Alere Inc.
9.5 Roche Holding
9.6 Bruker Corp.
9.7 Hologic Corporation
9.8 Cepheid Inc.
9.10 Thermo Fisher Scientific Inc.
9.11 List Not Exhaustive
10. Future Of The Market